Medium materiality5/10
GoodRx price target raised to $4 from $3.50 at Goldman Sachs
Why it may matterVerify against the original reporting
Moderate upside potential with target modestly above current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
GDRX target raised to $4; posted price $3.72.
- Goldman Sachs: GDRX target $4; price $3.72
Key facts
- 01
Target: $4
- 02
Posted price: $3.72
- 03
Analyst firm: Goldman Sachs
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.